Markets
Luke Kawa

Stocks rebound on auto tariffs delay

Call it the tariff two-step.

Many of the areas of the market most bedeviled by the imposition of tariffs on Mexico and Canada saw large relief rallies on Wednesday after the White House issued a one-month exemption for auto imports.

The S&P 500 rose 1.1%, the Nasdaq 100 gained 1.4%, and the Russell 2000 was up 1%.

Every S&P 500 sector ETF finished higher besides energy and utilities. Materials led the way higher, while healthcare, communication services, tech, consumer discretionary, and industrials all rose by more than 1%.

General Motors, Stellantis, and Ford were standout performers, all up more than 5%.

JetBlue, American Airlines, and United Airlines also advanced about as much thanks to the policy tweak.

Some stocks were also impacted by the president’s address to Congress on Tuesday night:

Intel dropped after Trump called for the CHIPS Act to be scrapped.

On the other hand, Huntington Ingalls Industries sailed higher, as it’s seen as a chief beneficiary of the president’s pledge to revitalize the domestic shipbuilding industry.

Earnings-related reactions of note:

CrowdStrike slumped after its outlook for this year was far worse than any Wall Street analyst anticipated.

Campbell’s fell after slashing its guidance.

Foot Locker’s fourth-quarter earnings per share exceeded expectations, taking the sting out of some lackluster guidance.

It was the opposite story for Abercrombie & Fitch, which tumbled after its earnings outlook for Q1 disappointed, even though its fourth-quarter results were in line with Wall Street’s forecasts.

ChargePoint’s top-line beat was enough to spur a big gain for the stock, even as policy headwinds loom for the EV charging company.

Other movers:

Moderna booked monster gains after reports that insiders made big purchases of the company and a German court ruled that Pfizer violated its Covid vaccine patent.

CEO Alex Karp’s big stock sales weren’t an overhang on Palantir Technologies today, with shares up more than 6%.

Chewy soared after its CFO talked up how the online pet product retailer was benefiting from a “premiumization” trend and Bank of America said it was one of the e-commerce companies most insulated from tariffs.

Alibaba popped higher as China’s leadership placed an even higher priority on boosting domestic consumption.

More Markets

See all Markets
markets

Sandisk rides Wall Street price target hikes toward new record

Sandisk leapt Friday, riding a resurgent wave of AI-related market exuberance as well as two price target hikes from Wall Street analysts.

Goldman Sachs lifted its target for the stock to $320 from $280, while keeping a “buy” rating on the stock. Mizhuho lifted its target to a Street high of $410 from its previous target of $250, while maintaining an “outperform” rating on the shares.

Long considered a maker of commodity data storage products, Sandisk was spun off by Western Digital in an IPO in February.

When it dawned on the market sometime in the fall that the AI boom would mean an explosion in demand for data storage, Sandisk shares went parabolic.

Its more than 350% run-up between the ends of August and December led to Sandisk’s inclusion in the S&P 500. And its 560% gain for the year made it the index’s top performer.

markets
Luke Kawa

It looks like the stock market was expecting some tariff relief

The S&P 500 briefly dipped into negative territory and tariff-sensitive stocks swung from big gains to big losses after the Supreme Court declined to give a ruling on tariffs imposed by President Donald Trump under the IEEPA.

A basket of “Trump Tariff Losers” stocks compiled by UBS, which includes Under Armour, American Eagle, Yeti, Mattel, and Deckers Outdoor, was up as much as 1.5% in early trading before falling as much as 1.7% after news of the lack of news surfaced.

The good news is that for the market as a whole (and even this group in particular), the pain seems to have been short-lived, with both bouncing back to erase losses.

It’s a decent little snapshot or case study to show that, yes, as prediction markets imply, the stock market is pricing in tariff relief.

markets

Amazon pharmacy to begin offering home delivery for Novo Nordisk’s Wegovy pill

Amazon Pharmacy announced Friday that it will offer Novo Nordisk’s recently approved weight-loss pill Wegovy, the newest frontier in the drugmaker’s push toward direct-to-consumer options.

Amazon said it will offer delivery for the pill through insurance and cash-pay options. Novos cash-pay price for the pill is $149 a month — less than half of what its injectables cost through the same channel.

Novo has partnered with big-box stores like Costco and Walmart as well as several big telehealth companies, including Ro, Weight Watchers, and LifeMD, to distribute the pill. This comes as the Danish pharma giant is trying to regain ground after Eli Lilly surpassed it in market share, in large part because of its early emphasis on direct-to-consumer channels.

The Food and Drug Administration approved Novos weight-loss pill in December, making it the first approved weight-loss pill to go to market. It has the same active ingredient, semaglutide, as its injectable products, Ozempic and Wegovy. Lillys oral version, orforglipron, is expected to come to market later this year.

markets

Intel gains after a favorable post from Trump

Intel continued its strong 2026 start by rising early Friday, following a favorable online post from President Trump, whose administration partially nationalized the ailing American chip giant in August.

In a Truth Social post Thursday afternoon, he praised CEO Lip-Bu Tan, boasted about the amount of money the government’s 10% investment in the company has made, and said, “Our Country is determined to bring leading edge Chip Manufacturing back to America, and that is exactly what is happening!!!”

Even after adjusting for the Trumpian tendency toward hyperbole, that last comment will be intriguing to Intel watchers. The company’s search to make deals with external customers willing to use its next-generation contract chip manufacturing business, crucial to the future of Intel’s ailing foundry business, will likely be a key driver of the stock price this year.

It’s not nuts to think that having the US government as a shareholder and the president as an active cheerleader — especially one who’s not shy about putting pressure on private sector companies to get what he wants — could be helpful in corralling reticent foundry customers.

Intel is up roughly 16% year to date and has more than doubled over the last year.

Even after adjusting for the Trumpian tendency toward hyperbole, that last comment will be intriguing to Intel watchers. The company’s search to make deals with external customers willing to use its next-generation contract chip manufacturing business, crucial to the future of Intel’s ailing foundry business, will likely be a key driver of the stock price this year.

It’s not nuts to think that having the US government as a shareholder and the president as an active cheerleader — especially one who’s not shy about putting pressure on private sector companies to get what he wants — could be helpful in corralling reticent foundry customers.

Intel is up roughly 16% year to date and has more than doubled over the last year.

Latest Stories

Sherwood Media, LLC produces fresh and unique perspectives on topical financial news and is a fully owned subsidiary of Robinhood Markets, Inc., and any views expressed here do not necessarily reflect the views of any other Robinhood affiliate, including Robinhood Markets, Inc., Robinhood Financial LLC, Robinhood Securities, LLC, Robinhood Crypto, LLC, or Robinhood Money, LLC.